Bioventus (BVS)
(Delayed Data from NSDQ)
$11.59 USD
-0.10 (-0.86%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $11.61 +0.02 (0.17%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth F Momentum B VGM
Earnings News For BVS
-
Bioventus Reports Second Quarter Financial Results
-
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
-
Bioventus Reports First Quarter Financial Results
-
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
-
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
-
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
-
Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023
-
Bioventus (BVS) to Report Q3 Earnings: What's in the Cards?
-
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
-
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
-
Bioventus Reports First Quarter Financial Results
-
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
-
Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
-
Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
-
Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
-
Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023
-
Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023
-
Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
-
Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
-
Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022
-
Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
-
Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022